Israel Englander Axsome Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 741,518 shares of AXSM stock, worth $54.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

741,518

Previous 909,965 18.51%

Holding current value

$54.4 Million

Previous $72.4 Million 18.3%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $11.7 Million - $16.4 Million	-168,447 Reduced 18.51%	741,518 $59.2 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $10 Million - $14.6 Million	174,862 Added 23.79%	909,965 $72.4 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $17.8 Million - $27.5 Million	-304,264 Reduced 29.27%	735,103 $52.8 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $60.7 Million - $78 Million	1,039,367 New	1,039,367 $64.1 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $133,025 - $257,676	3,689 Added 1.06%	351,140 $15.7 Million

Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $7.17 Million - $15.4 Million	329,798 Added 1868.23%	347,451 $13.3 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $1.61 Million - $2.81 Million	-68,006 Reduced 79.39%	17,653 $731,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $1.59 Million - $2.24 Million	-51,666 Reduced 37.62%	85,659 $3.24 Million
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $1.58 Million - $5.43 Million	-79,514 Reduced 36.67%	137,325 $4.53 Million
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $978,374 - $1.42 Million	-19,324 Reduced 8.18%	216,839 $14.6 Million
Q1 2021 May 17, 2021	BUY	$55.91 - $81.44 $4.88 Million - $7.1 Million	87,205 Added 58.54%	236,163 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $3.09 Million - $4.04 Million	46,639 Added 45.58%	148,958 $12.1 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $3.75 Million - $4.72 Million	-54,935 Reduced 34.93%	102,319 $7.29 Million
Q2 2020 Aug 14, 2020	BUY	$49.87 - $98.69 $245,510 - $485,850	4,923 Added 3.23%	157,254 $12.9 Million
Q1 2020 May 14, 2020	SELL	$41.2 - $101.31 $14.5 Million - $35.7 Million	-352,407 Reduced 69.82%	152,331 $8.96 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $1.81 Million - $11.5 Million	108,438 Added 27.36%	504,738 $52.2 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $137,308 - $197,821	6,784 Added 1.74%	396,300 $8.02 Million
Q2 2019 Aug 15, 2019	SELL	$13.46 - $25.75 $9.04 Million - $17.3 Million	-671,829 Reduced 63.3%	389,516 $10 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $4 Million - $7.66 Million	297,371 Added 38.92%	1,061,345 $35.5 Million
Q1 2019 May 14, 2019	BUY	$2.63 - $16.34 $1.2 Million - $7.44 Million	455,172 Added 147.4%	763,974 $10.9 Million
Q4 2018 Feb 14, 2019	BUY	$2.0 - $4.15 $617,604 - $1.28 Million	308,802 New	308,802 $871,000
Q1 2018 May 15, 2018	SELL	$2.35 - $5.6 $295,879 - $705,073	-125,906 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.45 - $6.2 $196,476 - $273,742	-44,152 Reduced 25.96%	125,906 $705,000
Q3 2017 Nov 14, 2017	BUY	$4.65 - $6.1 $790,769 - $1.04 Million	170,058	170,058 $944,000

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.15B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account